Qube Research & Technologies (QRT)’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-899,317
Closed -$62.6M 3899
2024
Q3
$62.6M Buy
899,317
+212,867
+31% +$14.6M 0.09% 279
2024
Q2
$46.2M Buy
686,450
+115,204
+20% +$7.76M 0.07% 312
2024
Q1
$39.4M Buy
571,246
+564,241
+8,055% +$38.1M 0.06% 370
2023
Q4
$436K Buy
+7,005
New +$392K ﹤0.01% 2372
2023
Q3
Sell
-59,036
Closed -$2.98M 4379
2023
Q2
$2.98M Sell
59,036
-2,532
-4% -$135K 0.01% 881
2023
Q1
$3.36M Buy
61,568
+21,969
+55% +$1.28M 0.01% 792
2022
Q4
$2.48M Buy
39,599
+14,074
+55% +$934K 0.01% 877
2022
Q3
$1.8M Buy
+25,525
New +$1.76M 0.01% 973
2021
Q4
Sell
-17,200
Closed -$1.12M 3063
2021
Q3
$1.12M Buy
17,200
+7,655
+80% +$522K 0.01% 871
2021
Q2
$605K Buy
+9,545
New +$563K 0.01% 1181

Other funds holding AXNX

Qube Research & Technologies (QRT)'s AXNX Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 899,317 shares — an estimated $62.6M sold.

Qube Research & Technologies (QRT) first reported a position in AXNX in Q2 2021 and held it in 10 quarters. The position peaked at $62.6M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 899,317 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $62.6M.
  • Qube Research & Technologies (QRT) first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s Axonics, Inc. Common Stock position peaked at $62.6M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.